BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19057876)

  • 1. Establishment and characterization of monoclonal antibodies against SARS coronavirus.
    Ohnishi K
    Methods Mol Biol; 2008; 454():191-203. PubMed ID: 19057876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies.
    Ohnishi K; Sakaguchi M; Kaji T; Akagawa K; Taniyama T; Kasai M; Tsunetsugu-Yokota Y; Oshima M; Yamamoto K; Takasuka N; Hashimoto S; Ato M; Fujii H; Takahashi Y; Morikawa S; Ishii K; Sata T; Takagi H; Itamura S; Odagiri T; Miyamura T; Kurane I; Tashiro M; Kurata T; Yoshikura H; Takemori T
    Jpn J Infect Dis; 2005 Apr; 58(2):88-94. PubMed ID: 15858286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay.
    Sunwoo HH; Palaniyappan A; Ganguly A; Bhatnagar PK; Das D; El-Kadi AO; Suresh MR
    J Virol Methods; 2013 Jan; 187(1):72-8. PubMed ID: 22995576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA.
    He Q; Du Q; Lau S; Manopo I; Lu L; Chan SW; Fenner BJ; Kwang J
    J Virol Methods; 2005 Jul; 127(1):46-53. PubMed ID: 15893565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
    Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
    Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
    Kariwa H; Noda H; Nakauchi M; Ishizuka M; Hashiguchi K; Hashimoto S; Yoshii K; Asano A; Agui T; Kogaki H; Kurano Y; Uchida Y; Fujii N; Okada M; Takashima I
    Jpn J Vet Res; 2008 Feb; 55(4):115-27. PubMed ID: 18380153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
    Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
    J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome.
    Che XY; Qiu LW; Pan YX; Wen K; Hao W; Zhang LY; Wang YD; Liao ZY; Hua X; Cheng VC; Yuen KY
    J Clin Microbiol; 2004 Jun; 42(6):2629-35. PubMed ID: 15184444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.
    Tripp RA; Haynes LM; Moore D; Anderson B; Tamin A; Harcourt BH; Jones LP; Yilla M; Babcock GJ; Greenough T; Ambrosino DM; Alvarez R; Callaway J; Cavitt S; Kamrud K; Alterson H; Smith J; Harcourt JL; Miao C; Razdan R; Comer JA; Rollin PE; Ksiazek TG; Sanchez A; Rota PA; Bellini WJ; Anderson LJ
    J Virol Methods; 2005 Sep; 128(1-2):21-8. PubMed ID: 15885812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.
    Rockx B; Corti D; Donaldson E; Sheahan T; Stadler K; Lanzavecchia A; Baric R
    J Virol; 2008 Apr; 82(7):3220-35. PubMed ID: 18199635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
    Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
    Suresh MR; Bhatnagar PK; Das D
    J Pharm Pharm Sci; 2008 Apr; 11(2):1s-13s. PubMed ID: 19203466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of monoclonal antibodies against SARS coronavirus and staining usage in lung autopsy specimens].
    Xu H; Ni AP; Lu ZH; Chen J
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1810-3. PubMed ID: 15631779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
    Woo PC; Lau SK; Wong BH; Chan KH; Chu CM; Tsoi HW; Huang Y; Peiris JS; Yuen KY
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):665-8. PubMed ID: 15242938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.
    Berry JD; Hay K; Rini JM; Yu M; Wang L; Plummer FA; Corbett CR; Andonov A
    MAbs; 2010; 2(1):53-66. PubMed ID: 20168090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay reveals high sensitivity of the nucleocapsid protein in acute-phase sera of severe acute respiratory syndrome patients.
    Di B; Hao W; Gao Y; Wang M; Wang YD; Qiu LW; Wen K; Zhou DH; Wu XW; Lu EJ; Liao ZY; Mei YB; Zheng BJ; Che XY
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):135-40. PubMed ID: 15642998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
    J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation and characterization of monoclonal antibodies against SARS-associated coronavirus nucleocapsid protein].
    Wang YB; Chang ZR; Wang JW; Ji R; Han CH; Zhao L; Ren LL; Chao YG; Qu JG; Qu CY; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):316-20. PubMed ID: 15650778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and identification of monoclonal antibodies against SARS-CoV putative protein X4].
    Luo X; Zhang T; Ma DL; Chen YY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):485-8. PubMed ID: 16224518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.